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Nuclear factor-kB, a ubiquitous transcription factor
involved in in¯ammatory and immune responses, is
inappropriately activated in several immuno-related
diseases, such as allograft rejection, or bronchial
asthma. As nuclear factor-kB activity is regulated by
inhibitor of kB (IkB), the gene encoding IkB-a was
disrupted in mice to observe the in vivo effects of
hyperactivation of nuclear factor-kB. IkB-a±/± mice
have constitutive nuclear factor-kB activity, severe
skin disease, and neonatal lethality. To determine the
role of IkB-a de®cient immunocytes in the patho-
genesis of the skin disease in adult mice, we utilized
the RAG2-de®cient blastocyst complementation sys-
tem to generate RAG2±/±, IkB-a±/± chimeras.
These animals display a psoriasiform dermatitis char-
acterized by hyperplastic epidermal keratinocytes
and dermal in®ltration of immunocytes, including
lymphocytes. Skin grafts transferred from diseased
chimeras to recipient nude mice produce hyperproli-
ferative psoriasiform epidermal keratinocytes in
response to stimulation. Furthermore, adoptive
transfer of lymph node cells from diseased chimeras
to RAG2±/± recipient mice recapitulates the disease.
Taken together, these characterizations provide evi-
dence to suggest that constitutive activation of
nuclear factor-kB, due to de®ciency in IkB-a, can
invoke severe psoriasiform dermatitis in adult mice.
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T
he ubiquitous transcription factor family, nuclear
factor-kB (NF-kB) is composed of ®ve vertebrate
DNA-binding proteins, including NF-kB1 (p50),
NF-kB2 (p52), cRel, RelA, and RelB. These
proteins bind DNA as dimers in a sequence-speci®c
manner to alter gene expression. NF-kB/Rel activity has been
demonstrated to be essential in regulating the expression of a
number of genes involved in in¯ammatory responses, immune
responses, acute phase reactions, and viral infection, as well as a
number of basic cellular functions, including proliferation,
differentiation and programmed cell death. In most cells, homo-
dimeric or heterodimeric NF-kB is retained in the cytoplasm by
association with an inhibitor of kB (IkB). The inhibitors of NF-kB
form an evolutionarily conserved multigene family with seven
vertebrate members, including IkB-a, IkB-b, Bcl3, IkB-g, p105,
p100, and IkB-e. Of these, IkB-a is recognized as a major regulator
of NF-kB activity. NF-kB is activated by a variety of signals,
including cytokines, bacterial and viral products, T and B cell
receptor cross-linking, T cell CD28, and B cell CD40. These signal
pathways converge on the phosphorylation and degradation of IkB,
releasing NF-kB complexes to translocate to the nucleus where
NF-kB can transcriptionally regulate target genes (reviewed in
Baldwin, 1996; Ghosh et al, 1998; Sha, 1998).
Several observations suggest that the aberrant activation of the
NF-kB/IkB family is involved in the development or progression
of diseases, such as autoimmune diseases, atherosclerosis, cancer,
and acute phase responses such as septic shock (Chen et al, 1999).
Several groups have observed a central role for NF-kB in these
disease processes. NF-kB is activated in the arthritic synovium
(Handel et al, 1995), and NF-kB activity may provide the link
between in¯ammation and hyperplasia that occurs in the arthritic
joint (Miagov et al, 1998). Inhibition of NF-kB in a T cell speci®c
fashion in mice results in a reduced incidence of collagen-induced
arthritis (Seetharaman et al, 1999). Like arthritis, the initiation and
progression of atherosclerosis involves in¯ammatory responses, as
well as the proliferation of vascular smooth muscle cells. Both
processes have been shown to involve NF-kB activation (Nakajima
et al, 1994; Berliner et al, 1995). Interestingly, NF-kB activity is
greatly elevated in mice susceptible to atherosclerosis, particularly
when fed with an atherogenic diet (Thurberg and Collins, 1998).
These diseases are all involved, to some extent, with the
deregulation of the immune response.
Psoriasis is a complex disorder of the skin and the immune
system and also involves genetic in¯uences (Christophers, 1996).
The two major abnormal characteristics of psoriasis are the
excessive growth of epidermal keratinocytes in the epidermis and
leukocyte in®ltration. The proliferating keratinocytes are juxta-
posed with immunocytes, including T lymphocytes, monocyte/
macrophages, and dermal dendritic cells (Barker, 1997). Mice that
are de®cient in IkB-a, the major inhibitor of NF-kB, display a
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severe skin phenotype that is reminiscent of human psoriasis, but
typically die within 9 d after birth. The elevated level of NF-kB
activity in hematopoietic cells of these mice may affect chronic
in¯ammatory responses resulting in the disease phenotype. Mice
lacking IkB-a also display excessive growth of keratinocytes and
the in®ltration of immunocytes (Beg et al, 1995; Klement et al,
1996). Several cytokines such as tumor necrosis factor (TNF) -a,
interleukin (IL) ±1, and IL-8, known to be involved in the
progression of psoriasis are also downstream targets of NF-kB.
Based on these observations and the role of NF-kB in multiple
other immuno-related diseases, it is reasonable to hypothesize that
the activation of NF-kB is involved in the pathology of psoriasis.
The neonatal lethality of IkB-a de®cient mice precludes study of
the function of IkB-a in adult lymphocytes or in the pathogenesis
of skin disease; however, use of the RAG2 (recombination activating
gene 2) blastocyst complementation system to generate chimeric
mice provides an alternative approach to study these questions
(Chen et al, 1993). This technique generates chimeras by injection
of normal or mutant embryonic stem cells (ES) cells into RAG2-
de®cient blastocysts. RAG2-de®cient mice do not have mature B
and T cells due to a de®ciency of the RAG2. Therefore, all mature
lymphocytes in the chimeras must be derived exclusively from
injected ES cells. The contribution of the otherwise normal
RAG2-de®cient cells to other cells of the resulting chimeras is able
to rescue the neonatal lethality phenotype enabling study of an
adult animal. This strategy has been used extensively to study the
role of several genes in B and T cell function, in circumstances that
would otherwise not be possible due to embryonic lethality (Chen,
1996). Using this system, we have created IkB-a±/±, RAG2±/±
chimeras. These chimeras display a psoriasiform dermatitis that can
be recapitulated by transferring the chimeric lymph node from
affected mice to RAG2±/± recipients. In response to stimulation,
skin grafts from affected chimeras to nude mice also generate
hyperplastic epidermal keratinocytes. Our characterizations provide
evidence to suggest that such chimeras will serve as a good model to
study psoriasis.
MATERIALS AND METHODS
Targeting vectors A mouse IkB-a gene, mad3, fragment was cloned
from a mouse 129 genomic library into gt11 phage. A KpnI (6.5 kb)
fragment was subcloned into pBluescript (pBS, Stratagene, La Jolla, CA).
The KpnI fragment contains both 5¢ and 3¢ ¯anking regions of IkB-a as
determined by diagnostic southern analysis. The fragment was used to
create the targeting construct. NarI was used to remove the 300 bp
nucleotides containing the 5¢-untranslated region and part of exon I region,
which was replaced with a PGK-Neo cassette in order to construct the
targeting vector, PGK-Neo IkB-a. This single selection construct, PGK-
Neo IkB-a was veri®ed by southern blot using external and internal
probes. To create the double selection construct, an XbaI fragment
containing pGK-Neo was subcloned into a PGK-tk plasmid to create a
PGK-tk Neo IkB-a construct.
ES cell culture and generation of mice Linearized targeting vector
(50 mg; was introduced into TL-1 ES cells (a gift from Trish Labosky) and
G418-resistant colonies were selected and cultured. DNA isolated from 610
colonies was digested with HindIII and SmaI and screened by southern
blotting using the KpnI/HindIII fragment as the external probe (probe a)
and Neo cassette as the internal probe (probe b). The probe a fragment was
isolated from a SmaI fragment subcloned into pBluescript from the same
gt11 phage clone. Four clones from a single selection and ®ve clones from a
double selection with a single targeted copy of IkB-a were identi®ed. Two
clones (nos 332 and 393) with a single targeted copy were used to generate
double targeted copies as described (Mortensen et al, 1991). Brie¯y, the
IkB-a+/± heterozygous ES cells were subjected to selection using 1 mg
per ml G418. The surviving clones were selected after 14 d. The double
targeted ES clones were veri®ed by southern blot using an internal probe
(probe c) and an external probe (probe a, data not shown). Eighty percent
of the surviving clones were double IkB-a±/± ES clones. Two clones were
selected and microinjected into RAG2-de®cient blastocysts as described
previously (Hogan et al, 1986). RAG2-de®cient mice (129/SvEvTacfBr-
[KO] rag-2) were obtained from Taconic Farms (Germantown, NY).
Chimeric offspring with reconstituted lymphocytes were veri®ed by
¯uorescence-activated cell sorter (FACS) analysis using peripheral blood
from 3 wk old mice. All ES cell lines and RAG2 null mice used were from
the same 129 SV strain background. All the mice used in this study were
maintained in a germ-free environment consisting of autoclaved water,
cage, and food. Animals were examined by veterinary staff and no signs of
infection were detected in affected animals or littermates.
Preparation of nuclear and cytoplasmic extracts Nuclear and
cytoplasmic extracts were prepared from spleen, thymus, and peripheral
blood cells as previously described (Alkalay et al, 1995). Brie¯y,
5 3 106 cells were resuspended in buffer A [10 mM 4-(2-hydroxyethyl)-
1-piperazine-ethane-sulfonic acid (pH 7.9); 10 mM KCl, 0.1 mM
ethylenediamine tetraacetic acid, 0.1 mM ethyleneglycol-bis(b-
aminoethyl ether)-N,N,N¢,N¢,-tetraacetic acid, 1 mM dithiothreitol;
1 mM phenylmethylsulfonyl¯uoride], and incubated ice for 15 min.
Nonidet P-40 was added to 1% vol/vol ®nal concentration, samples
were vortexed for 10 s and centrifuged at 12,000 3 g for 5 min. The
resulting supernatant containing the cytoplasmic fraction was frozen at
±70°C. Buffer C [420 mM NaCl, 20 mM 4-(2-hydroxyethyl)-1-
piperazine-ethane-sulfonic acid (pH 7.9; 1.5 mM MgCl2, 0.2 mM
ethylenediamine tetraacetic acid, 25% glycerol, 1 mM dithiothreitol,
1 mM phenylmethylsulfonyl¯uoride, 4 mg per ml leupeptin] was added to
the pellet, and the sample was agitated at 4°C for 30 min. The extract was
centrifuged at 12,000 3 g for 10 min and the supernatant containing the
nuclear fraction was frozen at ±70°C. Protein concentrations were
determined with Lowrie Assay (Bio-Rad, Herculus, CA).
Electrophoretic mobility shift assay An oligonucleotide
encompassing a kB DNA binding site (Stratagene, La Jolla, CA) was
end-labeled using g-P32-adenosine triphosphate. A reaction mixture
containing nuclear extract (4 mg) labeled probe (12,000 cpm); poly(dI±
dC) and bovine serum albumin (10 mg) was incubated in the presence of
binding buffer (20 mM HEPES pH 7.9, 5% vol/vol glycerol, 1 mM
ethylenediamine tetraacetic acid, 1% nonidet P-40, and 5 mM
dithiothreitol). DNA±protein complexes were resolved on a non-
denaturing 5% polyacrylamide gel and visualized by autoradiography
(Singh et al, 1986).
Ribonuclease protection assay Cytokine mRNA levels in the skin
were analyzed using the RiboQuant Multi-Probe RNase Protection Assay
System according to the manufacturer's instructions (PharMingen, San
Diego, CA). 32P-labeled anti-sense RNA templates speci®c for IL-4, IL-5,
TNF-a, granulocyte-macrophage colony-stimulating factor, macrophage
in¯ammatory protein-1a, IL-2, IL-6, g interferon-g), and controls L32 and
glyceraldehyde-3-phosphate dehydrogenase were transcribed using an
mCK-1 Custom Template Set (PharMingen). Total RNA was isolated
from the skin of the indicated mice using Tri-Reagent (Molecular
Research Center, Cincinnati, OH) according to the manufacturer's
instructions. Twenty micrograms of total RNA was analyzed per reaction.
Immuno¯uorescence staining and ¯ow cytometry Isolation of
single cell populations from thymus, spleen, peripheral blood, and bone
marrow was performed as described elsewhere (Boothby et al, 1997).
Dispersed cells were surface stained as described previously (Sha et al, 1995),
with directly ¯uoresceinated monoclonal antibodies (PharMingen). Stained
cells were subjected to analysis by FACScan ¯ow cytometer (Becton
Dickinson, San Jose, CA) The monoclonal antibodies used were: anti-B220
(PharMingen) (01125A), anti-CD4 (01065A), anti-CD8 (01044A), anti-
IgD (02214D), anti-IgM (1021-09; Southern Biotech, Birmingham, AL).
The FACS analysis was performed using Cell Quest program.
Preparation of puri®ed splenic B and T cells Spleen cells from
chimeras were ®rst depleted of erythrocytes by hydrolysis, followed by
incubation at 37°C in complete medium for 1 h to allow macrophage
attachment to the bottom of the plate. After macrophage depletion, the
suspended cells were gently transferred to 15 ml tubes and counted.
3 3 107 cells were incubated with 1.5 ml of anti-Thy 1.2, anti-CD4
(hybridoma G.K. 1.5), and anti-CD8 (hybridoma T105) hybridoma media
on ice for 40 min followed then washed. Cells were then transferred to
plates coated with anti-rat IgG (212±005±103; Jackson Immunoresearch
Lab., West Grove, PA) to deplete the T cell population and plated at 4°C
for 1 h. Spleen cells (3 3 107) were incubated in media containing anti-IgM
(Biosource Internal Inc, Camarilla, CA) bound plate at 4°C for 1 h to
deplete B cells. After panning out of B or T cells, the purity of T and B cell
populations was veri®ed by FACS analysis using anti-CD3 (01048A), anti-
B220, and anti-Mac-1 (01715B) antibodies (PharMingen). Normally, 80±
85% purity of B or T cells was obtained.
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Proliferation assays of B and T cells in culture All primary cells were
cultured in complete medium containing RPMI-1640 (GIBCO/BRL,
Rockville, MD) supplemented with 10% heat-inactivated fetal bovine
serum, 50 mM 2-mercaptoethanol, and 200 mM L-glutamine. Spleen cells
were plated at 1 3 106 leukocytes per ml. Puri®ed B and T cells were
cultured at concentrations of 1 3 106 cells per ml. For proliferation assays,
the puri®ed B or T lymphocytes were dispensed into 96-well microtiter
plates at 200 ml per well. B lymphocytes were stimulated with anti-IgM
20 mg per ml (Jackson Immunoresearch Laboratory, West Grove, PA), anti-
CD40 2 mg per ml (Pharmingen), and lipopolysaccharide 10 mg per ml
(Sigma, St Louis, MO). T lymphocytes were stimulated with concanavalin
A (2.5 mg per ml, Pharmacia), anti-CD3 (1/30 dilution, culture supernatant
of anti-CD3 hybridoma 140C11) in the presence of irradiated splenic cells
(5 3 105) from C57BL/6 mice for 48 h. Fresh medium containing 0.75 mCi
[3H]thymidine (Amersham, Piscataway, NJ) per well was added and
incubated for 16 h. Cells were harvested with a cell harvester (Tomtec,
Orange, CT), and uptake of radioactivity was measured with a betaplate
reader (Wallac, Gaithersburgh, MD).
Histologic analysis and immunohistochemistry Skin and spleens
from the 13 wk old chimeras (bone marrow recipients 5 wk after transfer)
were ®xed in 4% paraformaldehyde, embedded in paraf®n, and sectioned at
5 mm. Sections were stained with hematoxylin and eosin or used for
immunohistochemistry. Proliferating cellular nuclear antigen (PCNA)
immunoperoxidase staining was performed using a Vector ABC Elite
Mouse IgG Kit (PK-6102) and using anti-PCNA antibody (1486-772;
Roche, Indianapolis, IN). Epidermal thickness was measured as described
(Fraki et al, 1983). To rule out the possibility that the psoriasiform
dermatitis was induced by either bacterial or fungal agents, additional gram
staining and periodic acid-Schiff staining was performed on skin sections.
No evidence of bacterial or fungal infection was detected when sections
were examined from regions of skin most heavily affected by the
psoriasiform phenotype. Thus it seems highly unlikely that the
psorasiform dermatitis was induced by Corynebacterium bovis or
unclassi®ed fungal agents.
Bone marrow and lymph node transfer Bone marrow or lymph node
cells were taken from the chimeras at 13 wk of age as described elsewhere
(Boothby et al, 1997). To deplete mature B and T cells, bone marrow cells
were incubated with anti-thy 1.2, anti-CD4 (hybridoma G.K 1.5) and anti-
CD8 (hybridoma T105) for 45 min at 4°C. After washing with fresh cold
medium twice, bone marrow cells were incubated in plates precoated with
anti-rat IgG and anti-IgM m chain (Jackson Immunoresearch Laboratory)
antibodies for 45 min at 4°C. Then, 5 3 105 bone marrow cells were
injected into irradiated RAG2-de®cient mice. Lymph node cells
were injected into unirradiated-RAG2-de®cient mice at 2 3 106,
5 3 106, and 10 3 106 for RAG2±/±, IkB-a±/±, 4 (or 5) 3 106 for
RAG2±/±, IkB-a+/+.
Skin grafts Skin grafts were completed as described (Nanney et al, 1992).
Brie¯y, athymic nude mice (Taconic Farms) were anesthetized with an
intramuscular injection (0.1 ml) of Ketaset plus acepromazine and the
potential graft site, a full-thickness recipient bed measuring 2.5 3 2.5 cm,
was created on the dorsal surface of the mouse. The skins from chimeras
were divided into four individual grafts and one graft per mouse was ®xed
into position using Dermalon suture (Davis-Geck, Davis, CA). A
nonadherent bolster dressing (Release, Johnson and Johnson, Wayne,
PA) was sutured over the wound. Grafted mice were housed individually in
®lter-topped cages. The bolster dressings and sutures were removed after
7 d, and wound margins were allowed to heal for 8 wk. The grafted mice
were stripped with wax after 8 wk. Three days later, the stripped mice were
killed. The skins were prepared for histologic analysis.
RESULTS
Generation of RAG2±/±, IkB-a±/± chimeras The neonatal
lethality of IkB-a null mice precludes studying the effect of
constitutive NF-kB activity on adult lymphocytes and other tissues.
The RAG2-de®cient blastocyst complementation system provides
an alternative method to carry out these studies. RAG2-de®cient
mice have no mature B or T cells due to an inability to initiate
V(D)J recombination (Shinkai et al, 1992); however, injection of
normal or mutant ES cells into RAG2±/± blastocysts leads to the
generation of somatic chimeras. In such chimeras, all mature B and
T cells are derived from the injected ES cells. To investigate the
effect of constitutive NF-kB activation on adult lymphocytes, IkB-
a±/± ES cells were generated and injected into RAG2±/±
blastocysts to create chimeric adult mice. IkB-a±/± ES cells were
generated by subjecting two different IkB-a+/± ES cell lines to
elevated G418 selection. IkB-a±/± clones were veri®ed by
Southern analysis (Fig 1). Two representative IkB-a±/± clones
(nos 72 and 89) derived from two different ES IkB-a+/± lines (nos
332 and 393, respectively) were injected into RAG2±/± blastocysts.
Six injections into RAG2-de®cient blastocysts, two for each clone
of IkB-a±/± and control IkB-a+/+ ES cells, were completed.
Twenty-one pups were generated from IkB-a±/± ES cell
injections whereas 24 pups were generated from IkB-a+/+ ES
cell injections. As the ES cell clones and the RAG2±/± recipient
blastocysts are from the same 129 SV background, selection of
chimeras using coat color was not feasible. Thus selection of
chimeras for analysis was completed on the basis of reconstitution of
lymphocyte populations as determined by FACS analysis. Three
RAG2±/±, IkB-a±/± chimeras (72, 89, 72.2) and 12 control
RAG2±/±, IkB-a+/+ with reconstituted lymphocyte populations
were generated.
Figure 1. Targeted disruption of IkB-a gene in TL-1 ES cells. (A)
Schematics of IkB-a targeting constructs. Two targeting vectors, PGK-tk-
Neo IkB-a (double selection) and PGK-Neo IkB-a (single selection),
were used to disrupt the IkB-a gene via homologous recombination. A
schematic showing restriction enzyme sites within the IkB-a gene and
recombination locus is depicted. (B) Southern blot analysis identi®es IkB-
a±/± ES clones. Shown are examples of wild-type (+/+), heterozygous
(+/±), and homozygous (±/±) ES clones. DNA (10 mg) isolated from ES
clones was digested with HindIII/SmaI or BamHI and used for southern
blot analysis. The sizes of diagnostic fragments detected by southern blot
analysis are indicated. Probe a, an external probe, is a 0.7 kb HindIII/KpnI
fragment from the 3¢ end of IkB-a gene. Probe c, an internal probe, is a
0.4 kb fragment from the promoter region of IkB-a. The HindIII/SmaI
digest generates a 5 kb fragment diagnostic for the targeted allele. The
BamHI digest generates diagnostic fragments in which the 3 kb fragment
represents the targeted allele.
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RAG2±/±, IkB-a±/± chimeras develop severe skin
disease RAG2±/±, IkB-a±/± chimeras were normal at birth.
The most dramatic phenotype began to appear in two (nos 72 and
89) of the three chimeras at approximately 5 wk after birth when
the mice developed alopecia, characterized by hair loss around their
snout, ears, head, and neck regions. The underlying skin of these
chimeras was red, dry, scaly, ¯aky, and itchy, all signs indicative of
an in¯ammatory response of the skin. Skin punches taken from ear
lobes of RAG2±/±, IkB-a±/± mice contained evidence of
hyperkeratosis, epidermal hyperplasia, neutrophilic in®ltration to
the epidermis with microabscesses, and pustular psoriasis in the
affected animals. These effects were not observed in the RAG2±/±,
IkB-a+/+ animals or nonchimeric littermates. The severe skin
pathology ultimately extended over the entire surface of the mouse.
Upon sacri®ce, histologic specimens were prepared from snout,
ears, neck, dorsal surface, tail, and footpads. Histologic analyzes
reveal clear evidence of epidermal thickening and microabscess
formation (Fig 2A, C). In order to compare the epidermal
thickness of IkB-a±/± or wild-type reconstituted animals, a
standard formula was used to measure the skin layers (Fig 2B).
Dramatic differences were noted between RAG2±/±, IkB-a+/+
and RAG2±/±, IkB-a±/± mice in which 4.5-, 3.9-, 2.7, and 2.9-
fold increases in epidermal thickness were documented in snout,
ears, dorsal, and footpad regions, respectively (Fig 2B).
In order to determine if epidermal thickness in RAG2±/±, IkB-
a±/± mice might be due to hyperproliferation of skin keratino-
cytes, immunohistochemistry was performed using an antibody
against PCNA. A dramatic increase in PCNA-positive cells was
observed in RAG2±/±, IkB-a±/± skin within the epidermis
(Fig 2D). These proliferative keratinocytes were also present
superior to the basal layer, although increased PCNA+ cells were
noted in dermis as well. These results demonstrate one of the
hallmark characteristics of psoriasiform skin, the hyperproliferation
of epidermal keratinocytes in the presence of in®ltrating lympho-
cytes.
Lymphocyte development in RAG2±/±, IkB-a±/± mice All
mature B and T cells of chimeras should be derived from IkB-a-
de®cient ES cells, as RAG2 de®ciency precludes the generation of
mature B and T cells. To con®rm this and to determine the IkB-
a±/± contribution to the skin of chimeric animals, Southern
Figure 2. Histologic analysis of skin from diseased RAG2±/±, IkB-a±/± chimeras. (A) Hematoxylin and eosin-stained skin micrographs contrasting
the skin disease in the right panel showing a RAG2±/±, IkB-a±/± chimera with the left panel showing a RAG2±/±, IkB-a+/+ control chimera. (B) Table
showing the average epidermal thickness. Shown are representative measurements from two RAG2 ±/±, IkB-a±/± chimeras and two IkB-a+/+ control
chimeras. The data suggest that de®ciency in IkB-a alters the epidermal thickness in multiple body regions. (C) Hematoxylin and eosin staining of ear skin
removed at 5 wk of age from a severely affected RAG2±/±, IkB-a±/± chimera and an unaffected RAG2±/±, IkB-a+/+ control chimera. Mice de®cient for
IkB-a display a greatly thickened acanthotic epidermis with microabscesses and a dermal in®ltrate. (D) Immunoperoxidase staining comparing the
distribution and abundance of cells positive for PCNA in ear skin removed at 5 wk of age from an affected RAG2±/±, IkB-a±/± chimera and an unaffected
RAG2±/±, IkB-a+/+ chimera. Mice lacking in IkB-a show a dense lymphocytic in®ltrate in the thickened dermal region, and a greatly expanded
proliferative population within the basal epidermal compartment. Additional psoriasiform features include prominent acanthosis of the epidermis as well as a
focal parakeratosis (arrows). (A) 20 3; (C, D) 40 3. +/+: RAG2±/±, IkB-2+/+; ±/±: RAG2±/±, IkB-a±/±.
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analysis was performed to detect diagnostic fragments in genomic
DNA of chimeric tissue (Fig 3A). The results show variation in the
ef®ciency of reconstitution of the three chimeras (nos 72, 89, 72.2).
The vast majority of lymphocytes from thymus and spleen chimeras
are IkB-a±/± cells. This would be expected as reconstitution of the
lymphocyte population was criterion used to select chimeras for
analysis. Interestingly, the two chimeras (nos 72, 89) that display
disease have more than 50% of skin derived from IkB-a±/± ES cells
whereas the chimera that did not develop disease had less than 10%
of skin derived from IkB-a±/± ES cells.
To investigate the effects of IkB-a de®ciency on the activation
of NF-kB, nuclear extracts from peripheral blood, thymus, or
spleen cells were analyzed for NF-kB DNA-binding activity via
electrophoretic mobility shift assay. As expected, signi®cantly
elevated levels of NF-kB binding activity were evident in all IkB-
a±/± chimeras, consistent with IkB-a±/± de®ciency (Fig 3B).
This indicates that the absence of IkB-a leads to constitutive
activation of NF-kB in adult immunocytes.
To elucidate the effects of IkB-a de®ciency on the expression of
genes downstream of NF-kB that are potentially involved in skin
disease and in¯ammation, RNase protection assays were performed
using RNA from the skin of sick or control chimeras. TNF-a, a
cytokine known to be involved in acute in¯ammatory or acute
phase responses (Arai et al, 1990; Baumann and Gauldie, 1994) and
macrophage in¯ammatory protein-1a, involved in macrophage
activation (Schall et al, 1993), were elevated in the skin of
RAG2±/±, IkB-a±/± chimeras relative to control littermates
(Fig 3C). Other cytokines such as granulocyte-macrophage
colony-stimulating factor, IL-2, and interferon-g were not elevated
(data not shown). The results suggest that proin¯ammatory
cytokines regulated by NF-kB are upregulated in the absence of
IkB-a and may contribute to the dermatologic phenotype.
Given the critical role of NF-kB family members in lymphocyte
development (Sha, 1998), it might be hypothesized that constitu-
tive NF-kB activation advances immunocyte differentiation. To
test this idea, thymocytes, splenocytes, and peripheral lymphocytes
collected from RAG2±/±, IkB-a±/± chimeras and controls were
stained with antibodies that detect stage-speci®c markers of B and
T cells. FACS analysis of these cells with the T cell differentiation
markers, CD4 and CD8, revealed that the proportions of CD4+ or
CD8+ single positive cells from RAG2±/±, IkB-a±/± chimeras are
comparable with those from RAG2±/±, IkB-a+/+ chimeras
(Fig 4A). Interestingly, analysis of cells from RAG2±/±, IkB-a±/±
chimeras stained with B cell differentiation markers (B220, IgM,
and IgD) revealed that the proportion of cells expressing high levels
of surface IgM in the RAG2±/±, IkB-a±/± spleen cells were
elevated (approximately 2-fold) relative to controls (Fig 4B). The
levels of IgM on the IgD-positive population are elevated on the
surface of splenic cells from the RAG2±/±, IkB-a±/± chimeras
(Fig 4C±E). These results suggest that constitutive NF-kB
activation skews the development of B cells towards mature stages.
B and T cells from RAG2±/±, IkB-a±/± chimeras display
proliferation defects Animals de®cient in individual NF-kB
members have demonstrated that kB transcriptional activity is
critical for lymphocyte proliferation in response to B and T cell
speci®c stimuli (for review, Sha, 1998). In addition, use of the
trans-dominant inhibitor IkB-aDN has revealed that functional
inhibition of NF-kB transcriptional activation alters T and B cell ex
vivo proliferation (Boothby et al, 1997; Bendall et al, 1999). Thus,
we were interested in investigating the effects of constitutive NF-
kB activation on the proliferation of mature B and T cells. Spleen
cells isolated from RAG2±/±, IkB-a±/± chimeras and control
mice, and equal numbers of the enriched B and T cells were used to
measure ex vivo [3H]thymidine incorporation to investigate
induction of proliferation ability in response to indicated stimuli
(Fig 5). Analysis of T cells stimulated with anti-CD3 or
concanavalin A in the presence of antigen-presenting cells
showed decreased [3H]thymidine uptake in T cells from
RAG2±/±, IkB-a±/± chimeras as compared with those from
RAG2+/+, IkB-a+/+ animals. In contrast to results from T cells,
analysis of B cells treated with speci®c stimulators of B cells
(lipopolysaccharide, anti-IgM, anti-IgM plus anti-CD40, anti-
CD40) demonstrated an increased uptake of [3H]thymidine in B
cells from RAG2±/±, IkB-a±/± chimeras relative to wild-type
controls. These results indicate that constitutive NF-kB activation
alters the ex vivo proliferative ability of mature B and T cells in a
Figure 3. IkB-a±/± ES cells reconstitute lymphocyte populations
and disruption of IkB-a expression results in constitutive NF-kB
DNA binding activity and increased target gene expression. (A)
Southern blot analysis to con®rm that ES clones (72, 89) have reconstituted
thymus and spleen cells of RAG2±/±, IkB-a±/± chimeras (72, 72.2, 89).
Genomic DNA isolated from immunocytes was digested with BamHI and
the blot was probed with probe C from Fig 1. (B) Nuclear extracts (4 mg)
from secondary lymph organs of RAG2±/±, IkB-a±/± chimeras and
control littermates were subjected to electrophoretic mobility shift assay
using a human immunode®ciency virus-long terminal repeat kB binding
element as probe. Three independent experiments were completed from
three different mice (72, 72.2, 89). Shown are representative results
generated from the clone 89 chimera. Competitor oligo: 100 3. (C) RNase
protection assay indicates that the transcriptional levels of several cytokines,
including TNF-a and macrophage in¯ammatory protein-1a are elevated
in the skin from affected chimeras as compared with those from control
animals. L32 and glyceraldehyde-3-phosphate dehydrogenase are loading
controls. +/+: RAG2±/±, IkB-a+/+; ±/±: RAG2±/±, IkB-a±/±; 0:
RAG2 null control; IkB-a±/±: IkB-a null control.
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very different manner. The results shown are representative of all
three chimeras.
Lymph node adoptive transfer reproduces the psoriatic skin
phenotype in RAG2-de®cient mice It has been demonstrated
that adoptive transfer of a speci®c subset of lymphocytes can
recapitulate several immune diseases, including chronic
in¯ammation (Davidson et al, 1996). To explore the etiology of
the skin disorder of RAG2±/±, IkB-a±/± chimeras, cells from the
lymph node and bone marrow of affected chimeras or RAG2±/±,
IkB-a+/+ controls were adoptively transferred to untreated or
irradiated RAG2±/± de®cient mice. Nine untreated RAG2-
de®cient mice received lymphocytes from the lymph nodes of
RAG2±/±, IkB-a±/± chimeras. Six of the nine RAG2±/±
recipients received lymphocytes from chimeras 72 and 89, i.e.,
obviously sick mice. These recipients developed skin disease within
5 wk post-transfer whereas the recipients of cells from the 72.2
chimera, which itself did not develop skin disease, remained
healthy. Analysis of peripheral blood con®rmed that the
reconstituted lymphocyte population from affected chimeras is
comparable with those from controls (Fig 6A). Histologic analysis
of ear punches from sick recipients revealed a near identical
psoriasiform dermatitis to that observed in the RAG2±/±, IkB-
a±/± chimeras (Fig 6B). Interestingly, when the mice were
sacri®ced at 6 mo after transfer, the skin disease appeared less
severe, suggesting that as IkB-a±/± immunocytes aged and were
eliminated from the system, disease progression was attenuated.
These observations suggest that IkB-a±/± lymphocytes
signi®cantly contribute to the skin disease of affected chimeras
and that NF-kB activity may contribute to the progression of this
disease.
Six irradiated RAG2±/± mice received the mature B and T cell
depleted bone marrow cells from RAG2±/±, IkB-a chimeras.
Mice receiving bone marrow cells from affected chimeras appeared
normal for 4 wk, and then became ruf¯ed and hunched. Two
recipients died at approximately 6 wk post transfer. The remaining
four animals were sacri®ced for analysis. Recipients of wildtype
bone marrow remained healthy until killed at 6 wk post-transfer.
FACS analysis of bone marrow cells from recipients of RAG2±/±,
IkB-a±/± chimeras, sacri®ed prior to pathogenic death, revealed a
reduction in B cell precursors (Fig 6C). In agreement with this
®nding, fewer T and B cells were evident in the secondary lymph
organs analyzed including lymph nodes, spleen and thymus via
FACS relative to the cells from wild-type bone marrow recipients
(data not shown). Spleen sections from animals that received bone
marrow of affected mice contained reduced numbers of lympho-
cytes and lacked primary follicle structures (Fig 6D). Secondary
lymph organs of wild-type bone marrow recipients showed normal
reconstitution of lymphocyte populations (data not shown). The
cause of death of RAG2±/±, IkB-a±/± bone marrow recipients is
not known. Potentially, other hematopoietic stem cell populations
are also abnormal in bone marrow derived RAG2±/±, IkB-a±/±
animals and are therefore unable to reconstitute other critical cell
types.
Skin from affected chimeras retains the psoriatic phenotype
when grafted on nude mice Several lines of evidence suggest
that human skin diseases such as psoriasis can be transferred by skin
graft on to an immune-de®cient host (Sundberg et al, 1994;
Nickoloff et al, 1995). We wished to investigate whether the skin
disease in RAG2±/±, IkB-a±/± chimeras would be maintained in
grafts transferred to nude mice. Eight or 12 wk following grafting,
mice were stripped with wax to initiate an in¯ammatory response
and skin grafts were harvested after 3 d. Interestingly, the grafts
from affected chimeras still show the skin disease syndrome
Figure 5. Constitutive NF-kB activation alters T and B cell
proliferation in response to stimulation. Thymocytes and enriched B
and T cells (2 3 105) were plated in 96 wells in the absence or presence of
indicated stimulators. [3H]thymidine (0.75 mCi) was added to the wells after
48 h stimulation. Cells were collected 16 h after addition of [3H]thymidine
and then counted. Concanavalin A (5 mg per ml) and anti-CD3 (1:30
dilution from supernatant from hybridoma culture) in the presence of
irradiated antigen presenting cells, and phorbol myristate acetate (33.3 ng
per ml) and ionomycin (5 mM; were used to stimulate puri®ed T cells. IgM
(25 mg per ml) with or without anti-CD40 (2 mg per ml), anti-CD40 (2 mg
per ml) alone, or lipopolysaccharide (10 mg per ml) were used as B cell
speci®c stimulators. Shown are the results of RAG2±/±, IkB-a+/+ in
black bars and RAG2±/±, IkB-a±/± in white bars. Results are
representative of those from all three chimeras. Cells from each chimera
were analyzed in triplicate. Error bar = SD.
Figure 4. The effect of constitutive NF-kB activity on the devel-
opment of lymphocytes. (A) FACS analysis demonstrates the normal
development of IkB-a±/± T cells in RAG2±/±, IkB-a±/± chimeras.
Lymphocytes isolated from thymus, spleen, or peripheral blood were
stained with ¯uorescence-labeled CD4 and CD8 antibodies to determine
the differentiation status of T cells. (B) FACS analysis indicates the
proportion of IgMhiIgDhi cells is elevated in spleens of RAG2±/±, IkB-
a±/± chimeras. (C) The gate used for the histogram analysis of (D) and (E).
Histogram of FACS analysis indicates that the IgDlo (D) and IgDhi (E) IkB-
a±/± B cells have higher levels of IgM as compared with IkB-a+/+ B
cells. Shown are representatives of three mice.
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(Fig 7A). No involvement of recipient's skin was observed. To
investigate the proliferative status of keratinocytes, skin sections
from 8 wk and 12 wk grafts were examined for expression of
PCNA, a marker of cellular proliferation. Proliferating
keratinocytes in the skin grafts derived from affected chimeras
were greater in number than keratinocytes in grafts from wild-type
chimeras (Fig 7B). The thickness of grafts from affected chimeras is
three to four times greater than the grafts from control animals.
Interestingly, the thickness of the grafts was reduced at 12 wk as
compared with 8 wk (Fig 7C). These results indicate that
psoriasiform dermatitis can be maintained by grafts transferred
from affected chimeras, consistent with studies of human psoriasis
(Krueger et al, 1975; Nickoloff et al, 1995).
DISCUSSION
Mice lacking IkB-a have been independently created by three
groups, including the mice described here (Beg et al, 1995; Klement
et al, 1996). A phenotype common to all studies is a severe
psoriasiform dermatitis. The neonatal lethality of this knockout,
however, precludes the possibility of studying the interplay
between the keratinocytes and immunocytes in adult animals, both
of which are known to play crucial parts in the development of skin
diseases of humans (Nickoloff, 1998). Using a RAG2-de®cient
blastocyst complementation assay, we have created mosaic chimeras
of RAG2±/±, IkB-a±/± mice. Unlike the neonatal lethality
displayed by IkB-a-de®cient mice, these chimeric mice survive
into adulthood. Chimeras, however, display a skin disease similar to
that of IkB-a knockout mice, and also defects in the differentiation
and function of lymphocytes. This suggests that neonatal lethality of
IkB-a±/± is not exclusively due to the defects in the skin of these
animals. Furthermore, these chimeras provide a model to study not
only lymphocyte development but also pathogenesis of psoriasiform
dermatitis.
Effects of constitutive NF-kB activity on lymphocyte
development and proliferative response De®ciency in
individual NF-kB/IkB family members has minor effects on the
development of lymphocytes, but major effects on their
proliferative responses and immune function (reviewed in Sha,
1998). In addition, NF-kB activity is known to be involved in
regulating apoptosis. Our study shows that constitutive NF-kB
activity skews B cell development towards an advanced
differentiation stage, but has no apparent effect on T cell
Figure 6. Lymph node adoptive transfers reproduce the phenotype
of RAG2±/±, IkB-a±/± in RAG2-de®cient mice. Bone marrow
transfer recipients die. (A) FACS analysis indicates that reconstituted
lymphocytes derived from the lymph nodes of RAG2±/±, IkB-a±/±
chimeras are comparable with those from RAG2±/±, IkB-a+/+ chimeras.
(B) Lymphocytes collected from lymph nodes of RAG2±/±, IkB-a+/+ or
RAG2±/±, IkB-a±/± chimeras were injected into RAG2±/± mice. Ear
punch of recipients was sectioned and stained with hematoxylin and eosin.
Shown are results from skin sections of the recipients receiving 5 3 106 cells
from RAG2±/±, IkB-a+/+ or RAG2±/±, IkB-a±/± chimeras. Results are
representative of six recipients. The affected epidermis is greatly thickened,
increased dermal lymphocytic in®ltration is apparent, and a microabscess is
present at the epidermal surface. Table of the thickness of epidermis of skin
from the ear of lymph node recipients of RAG2±/±, IkB-a±/± and
RAG2±/±, IkB-a+/+. Results are representative of six recipients. (C)
FACS analysis of bone marrow cells taken from recipients 6 wk post-
transfer indicates that the B cell precursors are reduced in the recipients of
RAG-2±/±, IkB-a±/± bone marrow; however, the elevated level of CD43
indicates that the lymphoid or myeloid precursors are increased in the
recipients of RAG2±/±, IkB-a±/± bone marrow cells. Shown are
representatives of four recipients. (D) Histologic analysis of spleen indicates
that lymphocytes are reduced and spleen structure is altered in the
recipients of RAG2±/±, IkB-a±/± cells. Results are representative of four
recipients. (B) 40 3; (D) 20 3.
Figure 7. RAG2±/±, IkB-a±/± skin grafts demonstrate sustained
epidermal thickness in the absence of endogenous lymphocytes,
retain extensive proliferation and respond to trauma with an even
greater increase in epidermal thickness. Skin grafts from diseased and
control mice were transplanted on to nude recipients. Eight week post-
transfer, grafts were stimulated by the mild trauma of wax-stripping and
mice were killed 3 d later. (A) Histologic analysis indicating stripped skin
grafts from RAG2±/±, IkB-a±/± affected chimeras and controls. (B)
PCNA immunoperoxidase staining indicating the proliferating keratino-
cytes in the epidermal layer of skin grafts from RAG2±/±, IkB-a±/±
chimera. (C) Measurement of epidermal thickness of skin grafts from
affected chimeras to athymic nude mice. Results are representative of four
mice. (A) 20 3; (B) 40 3.
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development. In addition, our data show that IkB-a±/± B cells
have hyperproliferative responses to speci®c stimuli, whereas T cells
exhibit impaired proliferative responses. Our observations are
consistent with the ®ndings from studies of lymphocytes de®cient
in p105, another IkB family member (Ishikawa et al, 1998).
Whether these ®ndings are due to the effects of constitutive NF-kB
activity on apoptosis, differentiation, or cell cycle of lymphocytes
remains unclear.
Psoriasis, a chronic hyperproliferative skin disease affecting
approximately 1.5±2.0% of the Caucasian population, is character-
ized histologically by prominent keratinocyte hyperplasia and an
early in¯ammatory cell in®ltrate, including T lymphocytes and
macrophages. Studies on the pathophysiology of psoriasis have also
indicated that cytokines, including TNF-a, IL-1, IL-8, and
adhesion molecules, including integrins, endothelial cell adhesion
molecules, and vascular cell adhesion molecules are correlated with
this disease (Nickoloff, 1991). Several lines of evidence suggest that
the activity of NF-kB may be involved in the development of
psoriasis. Transgenic mice, which express human TNF-a under the
regulation of a keratin promoter, and mice expressing IL-1a from
the keratin 14 promoter (Cheng et al, 1992; Groves et al, 1995),
exhibit immune cell in®ltration of the dermis. These two cytokines
are well known as NF-kB activators (Beg et al, 1993). Several
cytokines and adhesion molecules involved in development of
psoriasis have been postulated to be downstream target genes of
NF-kB, including IL-1, IL-6, TNF-a, interferon-g, IL-8, vascular
cell adhesion molecule-1, endothelial cell adhesion molecule-1,
and intercellular adhesion molecule-1 (Nickoloff and Mitra, 1992;
Ghosh et al, 1998). This study detected changes in the levels of
TNF-a, and macrophage in¯ammatory protein-1a in the skin of
RAG2±/±, IkB-a±/± chimeras relative to control littermates.
Consistent with the ®ndings of other groups (Klement et al, 1996),
however, granulocyte-macrophage colony-stimulating factor, a
cytokine involved in the differentiation of granulocytes, and the
steady-state levels of IL-2 and interferon-g are not signi®cantly
changed (data not shown). High NF-kB activity has been observed
in the skin of transgenic mice expressing a reporter gene under the
control of NF-kB DNA binding elements (Frucht et al, 1991; Buzy
et al, 1995; F.E. Yull unpublished data). Alteration of NF-kB
activity affects the proliferation or apoptosis of keratinocytes (Seitz
et al, 1998; Wrone-Smith et al, 1997; Chaturvedi et al, 1999; Li et al,
1999). Psoriasis is known to occur in association with human
immunode®ciency virus infection, another well described inducer
of NF-kB (Johnson et al, 1985; Duvic, 1990). Based on these
observations and the fact that lack of IkB-a results in a severe
psoriasiform dermatitis characterized by hyperplastic keratinocytes
and immunocyte in®ltration, it is proposed that NF-kB activity
plays a pivotal stimulatory role in the pathogenesis of psoriasis.
In this study, we showed that RAG2±/± IkB-a±/± chimeras
develop a disease with features of psoriasiform dermatitis (Liu and
Parsons, 1983). Although the mice appear normal at 3 wk of age, by
5±6 wk old, the animals develop alopecia and mild scaling of the
skin that subsequently becomes more severe. After 7 wk the animals
suffer from severe pruritus demonstrated by frequent scratching.
Histologic analysis reveals a hyperproliferative epidermis, paraker-
atosis, microabcesses, and immunocyte in®ltration. This histo-
pathology is consistent with human psoriasis. Adoptive transfer of
lymph node cells from sick mice to unirradiated RAG2-de®cient
mice recapitulates the chronic psoriasiform dermatitis indicating
that hematopoietic cells, including lymphocytes are involved in the
development of this skin phenotype. Skin grafts from the affected
chimeras to athymic nude mice can sustain the hyperplastic
keratinocytes for periods of at least 12 wk. In summary, these
observations suggest that the RAG2±/±, IkB-a±/± chimeras
develop psoriasiform dermatitis.
The use of a severe combined immunode®cient mouse±human
skin model has revealed that psoriasis is an immunologically
mediated skin disease linked to several different class I major
histocompatibility complex alleles. Using this model, studies
reported from several groups indicated that T lymphocytes and
natural killer cells are involved in the pathogenesis of psoriasis
(Nickoloff and Wrone-Smith, 1997; Nickoloff, 1999; Nickoloff
et al, 1999). In this study, as only two of three RAG2±/±, IkB-
a±/± chimeras in which IkB-a±/± ES cells successfully recon-
stituted the lymphocyte populations display the cutaneous
phenotype, it appears that IkB-a±/± lymphocytes alone may not
be able to initiate the skin disease. Therefore, an interplay between
keratinocytes and immunocytes may be important for the process of
disease initiation and progression. This theory is strengthened by
the observation that there appears to be a requirement for an IkB-
a±/± component to the skin in addition to IkB-a null lymphocytes
in order to have a strong display of psoriasiform dermatitis. The
chimera, 72.2, which did not develop skin disease, had a very low
proportion of skin derived from IkB-a±/± ES cells. If an
interaction between IkB-a±/± skin and immunocytes was critical,
we would expect that lymph node or bone marrow adoptive
transfer from the sick mice would not be suf®cient to recapitulate
skin disease; however, some degrees of skin disease were produced
by the lymph node transfers. Perhaps an interplay between
keratinocytes and immunocytes is important for the initiation of
skin disease followed by a systemic effect, possibly upon cytokine
secretion, or adhesion molecule expression. This systemic effect
may result in fundamental changes to the lymphocyte population.
This lymphocyte population might then be suf®cient to initiate the
disease process after lymph node transfer. We have observed
increased expression of IL-2 receptors on the cell surface of T cells
from sick mice in the peripheral blood (data not shown), and the
elevated basal proliferation of T and B cells would suggest that these
lymphocytes are functionally changed. In addition, the lymph node
transfers from the nonskin disease RAG2±/±, IkB-a±/± chimera
(72.2) to the RAG2-de®cient mice did not produce psoriasiform
dermatitis, an observation consistent with the above hypothesis.
Skin grafts from the affected chimeras to athymic nude mice
retain the psoriasiform dermatitis for an extended time and provide
evidence to suggest that keratinocytes are important in disease
progression (Krueger et al, 1975). The observation that the severity
of skin disease is reduced after a lengthy period of time suggests that
the absence of abnormal hematopoietic cells allows the skin patch
to heal. Thus factors from abnormal hematopoietic IkB-a±/± cells
may be important in maintaining the skin disease.
Recently, numerous rodent models have emerged that exhibit
various psoriasiform abnormalities that appear similar to aspects of
human disease (SchoÈn, 1999). Studies with spontaneous mouse
mutations known as chronic proliferative dermatitis (cpd)
(HogenEsch et al, 1993) and ¯aky skin (fsn) suggest that epidermal
hyperproliferation and mixed in¯ammatory in®ltrate with neu-
trophilic accumulations in microabscesses (Sundberg et al, 1994) is
not dependent on T or B cell lymphocytes. Transgenic mice with
targeted epidermal overexpression of amphiregulin (Cook et al,
1997), bone morphogenesis protein-6 (Blessing et al, 1996) or
suprabasal integrin expression (Carroll et al, 1995) likewise develop
a psoriasiform phenotype. On the other hand, the T cell-mediated
immunopathogenesis of psoriasis has been well-established in
numerous human and mouse studies (Krueger et al, 1995;
Gottlieb et al, 1995; Wrone-Smith and Nickoloff, 1996; SchoÈn,
1999). The aberrant expression of multiple cytokines suggests that
no single signal transduction cascade is responsible for the
psoriasiform dermatitis (SchoÈn, 1999). This study provides
corroborating evidence of the pivotal nature of the NF-kB
pathway in the cascade of events that lead to the development of
psoriasis.
As lack of IkB-a results in constitutive NF-kB activity, increased
expression of targets such as cytokines and adhesion molecules may
contribute to the skin disease. The interaction of cytokines or
adhesion molecules with IkB-a±/± hematopoietic cells, including
lymphocytes may result in activation and recruitment of the
lymphocytes into the epidermal and dermal regions. The interplay
between the keratinocytes and activated lymphocytes may then
initiate keratinocyte hyperplasia as observed in the RAG2±/±, IkB-
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a±/± animals. We are currently designing experiments to test this
model.
To further develop this model, highly ef®cient reconstitution of
chimeras by IkB-a±/± ES cells is required. The low ef®ciency of
reconstitution by the IkB-a±/± ES cells used in this study was
noted. To circumvent this issue, we are generating IkB-a±/± ES
cells from 3.5 d IkB-a±/± blastocysts. Large numbers of chimeras
will be generated from these ES cells to study factors or adhesion
molecules, which are required for the interplay between keratino-
cytes and immunocytes. These chimeras will be used to study both
topical and systemically delivered therapeutic agents, which may
attenuate or reverse the psoriatic phenotype.
In summary, IkB-a±/± de®ciency results in a mouse model of
psoriasiform dermatitis, which can be studied in vivo in adult
animals by variety of methods, including blastocyst complementa-
tion, adoptive transfer, and skin grafting. The interplay between the
immune system and the keratinocytes is based on the results
described herein. Further studies will utilize this powerful system to
study the physiologic role of cytokines and adhesion molecules in
the pathogenesis of psoriasis, and to develop the therapeutic agents
to treat this disease.
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